MIT engineers developed a new way to amplify the T cell response to mRNA vaccines, using an mRNA adjuvant. This approach could lead to much more powerful cancer vaccines and stronger protection against infectious diseases.

 

Experts from the University of Plymouth’s Brain Research and Imaging Centre and the University of Exeter Medical School believe the results of a new study lay important groundwork for exploring the therapeutic use of transcranial ultrasound stimulation (TUS) in people experiencing chronic pain through conditions including fibromyalgia, back pain and arthritis, or while they are recovering after cancer treatment.

A research team led by the Medical University of Vienna has demonstrated in a recent study that the biological characteristics of a subgroup of head and neck tumours – which are very aggressive in many cases – are reflected in modern imaging techniques. PET/CT scans can thus provide clues to particularly active and prognostically unfavourable tumour types, thereby opening up new prospects for personalised treatment strategies for a type of cancer that has hitherto been difficult to treat. The results were published in the journal Molecular Cancer.

In this cohort study of individuals with stage IV breast cancer, incidence increased significantly overall, across ages, and for both sexes from 2010 through 2021. The percentage of individuals with stage IV vs stages I to III diagnoses also increased. Although overall survival improved, research is warranted to determine factors contributing to increased incidence, including potential changes in natural history of breast cancer, disease screening, and incidence and mortality of other conditions.

Ivermectin-benzimidazole prescribing rose rapidly following celebrity endorsement in January 2025, with disproportionate increases among male patients, white patients, residents of the U.S. South, and individuals with cancer. The elevated prescribing observed among patients with cancer is particularly concerning; individuals facing life-threatening illness may delay or forgo conventional treatments in favor of unproven therapies, potentially allowing their disease to progress.